by Elec23 | Jan 28, 2026 | News&events, VisMederi
VisMederi is reinforcing its strategic role as a reference laboratory for global epidemic and pandemic preparedness, with a specific focus over the past year on the development, standardization, and validation of serological testing for Nipah virus (NiV). The timing...
by Elec23 | Apr 7, 2025 | News&events
Emanuele Montomoli (CSO & Founder) and Alessandro Manenti (CDO) are co-authors of a new scientific publication on a Phase II/III clinical study evaluating the immunogenicity, safety, and tolerability of a new SARS-CoV-2 booster vaccine. The study represents an...
by Elec23 | Oct 18, 2024 | News&events
VisMederi is pleased to announce the publishing of a collaborative study with GVGH (GSK Vaccines Institute for Global Health) that highlights a significant achievement in vaccine research. This recent study, published in Frontiers in Immunology, describes the creation...
by Elec23 | Sep 24, 2024 | News&events
Fondazione VisMederi has signed an agreement with Trialect Inc., USA, for the program entitled “Trialect Global Medical Education Program.” This initiative aims to provide short-term training and education for biomedical scientists and physicians to enhance the...
